We cooperated with Evident Corporation (formerly Olympus) in evaluating their new product CM20 and creating an application note.


We evaluated Olympus’ new product, the CM20, and assisted in the creation of an application note.
Click here for details.
       
In addition, we held an online seminar on the following topic on Wednesday, September 15, 2021, from 1:00 PM to 2:00 PM.

Topic: “Assay Methods for Cultured Cells Using the CM20 – Aiming for Easier and More Accurate Measurement Methods for Cell Proliferation/Cytotoxicity Analysis”
        
Speaker: Takahiro Yamaguchi, Principal Investigator, ACEL, Inc.
        
To verify the feasibility of using Olympus’ CM20 for cell proliferation and toxicity evaluation, we reported on the results of a comparison between the conventional method (WST-8) and the CM20 for two assays: “Anti-cancer drug (5-FU)-induced cell death assay in human lung adenocarcinoma A549 cells” and “Neurotoxin (6-OHDA)-induced cell death assay in human neuroblastoma SH-SY5Y cells.”

You can watch the seminar here.